| Home : October 2010 : October 02, 2010 News : Maven Biotechnologies Receives $1.96 Million From the National Institutes of Health (NIH) to Develop Their LFIREâ„¢ Label-Free Detection Technology for Proteomics |
Maven Biotechnologies Receives $1.96 Million From the National Institutes of Health (NIH) to Develop Their LFIREâ„¢ Label-Free Detection Technology for Proteomics |
October 02, 2010
PASADENA, Calif., Oct. 1 /PRNewswire/ -- Maven Biotechnologies today announced that the company has been awarded $1.96 million by the National Institute for Allergy and Infectious Disease (NIAID), part of the NIH, to support the commercialization of their LFIRE™ imaging technology for label-fr
http://www.prnewswire.com/news-releases/maven-biotechnologies-receives-196-million-from-the-national-institutes-of-health-nih-to-develop-their-lfire-label-free-detection-technology-for-proteomics-104187213.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
